{"id":"https://openalex.org/W2145834141","doi":"https://doi.org/10.4049/jimmunol.1301737","title":"Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti\u2013IL-17 Receptor Monoclonal Antibody","display_name":"Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti\u2013IL-17 Receptor Monoclonal Antibody","publication_year":2014,"publication_date":"2014-03-20","ids":{"openalex":"https://openalex.org/W2145834141","doi":"https://doi.org/10.4049/jimmunol.1301737","mag":"2145834141","pmid":"https://pubmed.ncbi.nlm.nih.gov/24646743"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.1301737","doi":"https://doi.org/10.4049/jimmunol.1301737","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.1301737","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070208317","display_name":"Chris B. Russell","orcid":"https://orcid.org/0000-0002-0240-1815","observed_orcids":["https://orcid.org/0000-0002-0240-1815"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris B Russell","raw_affiliation_strings":["Amgen , Seattle, WA 98119"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen , Seattle, WA 98119","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037593913","display_name":"Hugh A. Rand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hugh Rand","raw_affiliation_strings":["Amgen , Seattle, WA 98119"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen , Seattle, WA 98119","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016248991","display_name":"Jeannette Bigler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeannette Bigler","raw_affiliation_strings":["Amgen , Seattle, WA 98119"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen , Seattle, WA 98119","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072615236","display_name":"Keith Kerkof","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Keith Kerkof","raw_affiliation_strings":["Amgen , Seattle, WA 98119"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen , Seattle, WA 98119","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039498179","display_name":"Martin Timour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Martin Timour","raw_affiliation_strings":["Amgen , Seattle, WA 98119"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen , Seattle, WA 98119","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Edgar Bautista","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edgar Bautista","raw_affiliation_strings":["Amgen , Thousand Oaks, CA 91320","\u2020Amgen, Thousand Oaks, CA 91320; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen , Thousand Oaks, CA 91320","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"\u2020Amgen, Thousand Oaks, CA 91320; and","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080337749","display_name":"James G. Krueger","orcid":"https://orcid.org/0000-0002-3775-1778","observed_orcids":["https://orcid.org/0000-0002-3775-1778"]},"institutions":[{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James G Krueger","raw_affiliation_strings":["\u2021Rockefeller University, New York, NY 10065"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2021Rockefeller University, New York, NY 10065","institution_ids":["https://openalex.org/I83399316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006305632","display_name":"David H. Salinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David H Salinger","raw_affiliation_strings":["Amgen , Seattle, WA 98119"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen , Seattle, WA 98119","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043655994","display_name":"Andrew A. Welcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew A Welcher","raw_affiliation_strings":["Amgen , Thousand Oaks, CA 91320","\u2020Amgen, Thousand Oaks, CA 91320; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen , Thousand Oaks, CA 91320","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"\u2020Amgen, Thousand Oaks, CA 91320; and","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":null,"display_name":"David A Martin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A Martin","raw_affiliation_strings":["Amgen , Seattle, WA 98119"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen , Seattle, WA 98119","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5016248991","https://openalex.org/A5037593913","https://openalex.org/A5039498179","https://openalex.org/A5072615236"],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":6.8483,"has_fulltext":false,"cited_by_count":161,"citation_normalized_percentile":{"value":0.97676061,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"192","issue":"8","first_page":"3828","last_page":"3836"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9259999990463257},{"id":"https://openalex.org/keywords/brodalumab","display_name":"brodalumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/il-17-receptor-a","display_name":"IL-17 receptor A","score":0.7979999780654907},{"id":"https://openalex.org/keywords/il-17-signaling","display_name":"IL-17 signaling","score":0.8970000147819519},{"id":"https://openalex.org/keywords/gene-expression-normalization","display_name":"gene expression normalization","score":0.8389999866485596},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.875},{"id":"https://openalex.org/keywords/il-17a","display_name":"IL-17A","score":0.8489999771118164},{"id":"https://openalex.org/keywords/il-17f","display_name":"IL-17F","score":1.0},{"id":"https://openalex.org/keywords/keratinocyte-hyperplasia","display_name":"keratinocyte hyperplasia","score":0.9240000247955322},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.7289999723434448},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.7329999804496765},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.3580000102519989}],"concepts":[{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7166316509246826},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.6238834261894226},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5177804231643677},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48105931282043457},{"id":"https://openalex.org/C2777074287","wikidata":"https://www.wikidata.org/wiki/Q1473931","display_name":"Keratinocyte","level":3,"score":0.45396479964256287},{"id":"https://openalex.org/C47348012","wikidata":"https://www.wikidata.org/wiki/Q99486570","display_name":"Interleukin 17","level":3,"score":0.4492560029029846},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.2997327446937561},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.2597794532775879},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.22927743196487427},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1592516303062439},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.0896434485912323}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016000","descriptor_name":"Cluster Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020381","descriptor_name":"Interleukin-17","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020381","descriptor_name":"Interleukin-17","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053722","descriptor_name":"Receptors, Interleukin-17","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D059467","descriptor_name":"Transcriptome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4049/jimmunol.1301737","doi":"https://doi.org/10.4049/jimmunol.1301737","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.1301737","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:24646743","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24646743","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunology (Baltimore, Md. : 1950)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1502229195","https://openalex.org/W1506160581","https://openalex.org/W1560379370","https://openalex.org/W1587026990","https://openalex.org/W1969790434","https://openalex.org/W1979058179","https://openalex.org/W1981177225","https://openalex.org/W1982598880","https://openalex.org/W1984846010","https://openalex.org/W1993273784","https://openalex.org/W2000851235","https://openalex.org/W2012077729","https://openalex.org/W2019678439","https://openalex.org/W2021018799","https://openalex.org/W2023733075","https://openalex.org/W2027941153","https://openalex.org/W2032039720","https://openalex.org/W2034453891","https://openalex.org/W2049148913","https://openalex.org/W2062291274","https://openalex.org/W2073441708","https://openalex.org/W2079267030","https://openalex.org/W2080697619","https://openalex.org/W2086210534","https://openalex.org/W2088569180","https://openalex.org/W2100474263","https://openalex.org/W2103018315","https://openalex.org/W2112128505","https://openalex.org/W2116956799","https://openalex.org/W2121900420","https://openalex.org/W2127834887","https://openalex.org/W2146843653","https://openalex.org/W2151991135","https://openalex.org/W2152711020","https://openalex.org/W2161244971","https://openalex.org/W2163778689","https://openalex.org/W2167428789","https://openalex.org/W2322390243","https://openalex.org/W4210999603","https://openalex.org/W4230096730","https://openalex.org/W4233561050","https://openalex.org/W4248269869","https://openalex.org/W6645172339"],"related_works":["https://openalex.org/W2997602829","https://openalex.org/W3151719606","https://openalex.org/W4414573757","https://openalex.org/W3015565870","https://openalex.org/W3011433060","https://openalex.org/W4386723850","https://openalex.org/W7160285152","https://openalex.org/W1982598880","https://openalex.org/W2801383894","https://openalex.org/W4416586112"],"abstract_inverted_index":{"The":[0,85],"IL-17":[1,21,38,87,180,186,207],"pathway":[2],"is":[3],"an":[4],"established":[5],"driver":[6],"of":[7,18,20,36,43,59,144,172,179,185,197,206,233],"psoriasis":[8,62,150,199],"pathogenesis.":[9,241],"We":[10],"examined":[11],"the":[12,37,60,138,149,170,177,189,198,225,230,234],"detailed":[13],"molecular":[14,161,165],"and":[15,28,98,126,148,164,183,228],"cellular":[16],"effects":[17],"blockade":[19,205],"signaling":[22,187,208],"in":[23,47,68,93,103,120,128,209,218,224,238],"human":[24],"psoriatic":[25,210],"skin":[26,49,211],"before":[27],"following":[29,54,107],"treatment":[30],"with":[31,57,117,137,154,195],"brodalumab,":[32],"a":[33,104,114,133],"competitive":[34],"inhibitor":[35],"Receptor":[39],"A":[40],"subunit.":[41],"Thousands":[42],"aberrantly":[44],"expressed":[45],"genes":[46,72,89,147],"lesional":[48,61,94],"normalized":[50],"within":[51,123],"2":[52],"weeks":[53],"brodalumab":[55,108,140,173],"treatment,":[56],"conversion":[58],"transcriptome":[63],"to":[64,74,176,213],"resemble":[65],"that":[66,90,204],"seen":[67],"nonlesional":[69,190],"skin.":[70],"Keratinocyte-expressed":[71],"appeared":[73,167],"normalize":[75],"rapidly,":[76],"whereas":[77,152],"T":[78],"cell-specific":[79],"normalization":[80,143,196,223],"occurred":[81,131],"over":[82,132],"six":[83],"weeks.":[84],"three":[86],"ligand":[88,181],"are":[91],"upregulated":[92],"skin,":[95],"IL17A,":[96],"IL17C,":[97],"IL17F,":[99],"were":[100],"all":[101],"downregulated":[102],"dose-dependent":[105],"manner":[106],"treatment.":[109],"Cellular":[110],"measures":[111],"also":[112],"showed":[113,142,157],"similar":[115],"pattern":[116],"dramatic":[118],"decreases":[119,127],"keratinocyte":[121],"hyperplasia":[122],"one":[124],"week,":[125],"infiltrating":[129],"leukocytes":[130],"longer":[134],"timescale.":[135],"Individuals":[136],"highest":[139],"exposure":[141,174],"both":[145],"IL-17-responsive":[146],"transcriptome,":[151],"subjects":[153],"lower":[155],"exposures":[156],"transient":[158],"or":[159],"incomplete":[160],"responses.":[162],"Clinical":[163],"response":[166],"dependent":[168],"on":[169,236],"extent":[171],"relative":[175],"expression":[178],"genes,":[182,220],"reduction":[184],"into":[188],"range":[191],"was":[192],"strongly":[193],"correlated":[194],"transcriptome.":[200],"These":[201],"data":[202],"indicate":[203],"leads":[212],"rapid":[214],"transcriptomal":[215],"changes":[216],"initially":[217],"keratinocyte-expressed":[219],"followed":[221],"by":[222],"leukocyte":[226],"abnormalities,":[227],"demonstrates":[229],"essential":[231],"role":[232],"IL-17R":[235],"keratinocytes":[237],"driving":[239],"disease":[240]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}